IN8bio, Inc.
INAB
$1.75
-$0.03-1.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.69M | 13.23M | 11.89M | 11.12M | 4.00M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 733.00K | 145.00K | 410.00K | 1.16M | 2.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 346.00K | 370.00K | 427.00K | 298.00K | 177.00K |
| Total Current Assets | 11.77M | 13.74M | 12.73M | 12.58M | 6.70M |
|
|
|||||
| Total Current Assets | 11.77M | 13.74M | 12.73M | 12.58M | 6.70M |
| Net Property, Plant & Equipment | 4.56M | 5.08M | 6.60M | 7.83M | 8.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 442.00K | 546.00K | 544.00K | 541.00K | 764.00K |
| Total Assets | 16.77M | 19.37M | 19.87M | 20.94M | 15.97M |
|
|
|||||
| Total Accounts Payable | 204.00K | 379.00K | 575.00K | 389.00K | 1.14M |
| Total Accrued Expenses | 418.00K | 635.00K | 1.15M | 1.05M | 769.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.08M | 940.00K | 1.24M | 1.65M | 1.73M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.70M | 1.95M | 2.96M | 3.08M | 3.64M |
|
|
|||||
| Total Current Liabilities | 1.70M | 1.95M | 2.96M | 3.08M | 3.64M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.88M | 2.18M | 3.04M | 3.38M | 3.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.58M | 4.13M | 5.99M | 6.47M | 7.38M |
|
|
|||||
| Common Stock & APIC | 149.34M | 147.54M | 141.08M | 136.13M | 124.08M |
| Retained Earnings | -136.15M | -132.30M | -127.21M | -121.66M | -115.50M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 13.19M | 15.24M | 13.88M | 14.48M | 8.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.19M | 15.24M | 13.88M | 14.48M | 8.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.19M | 15.24M | 13.88M | 14.48M | 8.59M |
|
|
|||||